Posts By: CRB
Cyclic peptides are of increasing interest in drug discovery projects because the cyclic structure allows pharmacophores to be arranged in an optimal conformation for receptor binding and/or because cyclic peptides are resistant to peptidases and hence more stable making them more potent and longer acting.
Cambridge Research Biochemicals® (CRB), a British company specialising in custom peptides and bespoke antibodies for the Pharmaceutical industry and for medical research, today announced the release of its new Discovery Peptides® catalogue.
I’m not going to go into any detail about the opening of CRB’s new building, the Gardner Ratcliffe Building on Wednesday, 17thSeptember 2014, mainly because you can read a full account of the event. Instead, here are a few personal thoughts, observations and reminiscences prompted by what was a very happy day. The first happy… Read more »